Cargando…
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911489/ https://www.ncbi.nlm.nih.gov/pubmed/35996039 http://dx.doi.org/10.1007/s11136-022-03232-w |
_version_ | 1784885000517189632 |
---|---|
author | Michel, Maurice Wahl, Alisha Anders, Malena Alqahtani, Saleh A. Kremer, Wolfgang M. Galle, Peter R. Labenz, Christian Grimm, Daniel Sprinzl, Martin Schattenberg, Jörn M. |
author_facet | Michel, Maurice Wahl, Alisha Anders, Malena Alqahtani, Saleh A. Kremer, Wolfgang M. Galle, Peter R. Labenz, Christian Grimm, Daniel Sprinzl, Martin Schattenberg, Jörn M. |
author_sort | Michel, Maurice |
collection | PubMed |
description | PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03232-w. |
format | Online Article Text |
id | pubmed-9911489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-99114892023-02-11 Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV Michel, Maurice Wahl, Alisha Anders, Malena Alqahtani, Saleh A. Kremer, Wolfgang M. Galle, Peter R. Labenz, Christian Grimm, Daniel Sprinzl, Martin Schattenberg, Jörn M. Qual Life Res Article PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03232-w. Springer International Publishing 2022-08-22 2023 /pmc/articles/PMC9911489/ /pubmed/35996039 http://dx.doi.org/10.1007/s11136-022-03232-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Michel, Maurice Wahl, Alisha Anders, Malena Alqahtani, Saleh A. Kremer, Wolfgang M. Galle, Peter R. Labenz, Christian Grimm, Daniel Sprinzl, Martin Schattenberg, Jörn M. Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title | Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title_full | Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title_fullStr | Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title_full_unstemmed | Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title_short | Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV |
title_sort | significant liver fibrosis is a predictor of poor health-related quality of life in people living with hiv |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911489/ https://www.ncbi.nlm.nih.gov/pubmed/35996039 http://dx.doi.org/10.1007/s11136-022-03232-w |
work_keys_str_mv | AT michelmaurice significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT wahlalisha significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT andersmalena significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT alqahtanisaleha significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT kremerwolfgangm significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT gallepeterr significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT labenzchristian significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT grimmdaniel significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT sprinzlmartin significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv AT schattenbergjornm significantliverfibrosisisapredictorofpoorhealthrelatedqualityoflifeinpeoplelivingwithhiv |